![](/images/graphics-bg.png)
Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia
المؤلفون المشاركون
Luo, Wei-Feng
Liu, Jing
Xu, Ying-Ying
Zhang, Qi-Lin
المصدر
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-5، 5ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-04-05
دولة النشر
مصر
عدد الصفحات
5
التخصصات الرئيسية
الملخص EN
Objective.
To assess the therapeutic efficacy and safety of botulinum toxin type A (BTX-A) for treating idiopathic trigeminal neuralgia (ITN) in patients ≥80 years old.
Methods.
Selected patients n=43 with ITN, recruited from the neurology clinic and inpatient department of the Second Affiliated Hospital of Soochow University between August 2008 and February 2014, were grouped by age, one subset n=14 ≥80 years old and another n=29 <60 years old.
Each group scored similarly in degrees of pain registered by the visual analogue scale (VAS).
Dosing, efficacy, and safety of BTX-A injections were compared by group.
Results.
Mean dosages of BTX-A were 91.3 ± 25.6 U and 71.8 ± 33.1 U in older and younger patients, respectively t=1.930, p=0.061.
The median of the VAS score in older patients at baseline (8.5) declined significantly at 1 month after treatment (4.5) p=0.007, as did that of younger patients (8.0 and 5.0, resp.) p=0.001.
The median of the D values of the VAS scores did not differ significantly by group (older, 2.5; younger, 0; Z=−1.073, p=0.283).
Two patients in each group developed minor transient side effects p=0.825.
Adverse reactions in both groups were mild, resolving spontaneously within 3 weeks.
Conclusions.
BTX-A is effective and safe in treating patients of advanced age (≥80 years old) with ITN, at dosages comparable to those used in much younger counterparts (<60 years old).
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Liu, Jing& Xu, Ying-Ying& Zhang, Qi-Lin& Luo, Wei-Feng. 2018. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia. Pain Research and Management،Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1212601
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Liu, Jing…[et al.]. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia. Pain Research and Management No. 2018 (2018), pp.1-5.
https://search.emarefa.net/detail/BIM-1212601
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Liu, Jing& Xu, Ying-Ying& Zhang, Qi-Lin& Luo, Wei-Feng. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia. Pain Research and Management. 2018. Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1212601
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1212601
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)